Status:
RECRUITING
National Pregnancy Registry for Psychiatric Medications
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
Alkermes, Inc.
Eisai Inc.
Conditions:
Pregnant Women
Psychotropic Drugs
Eligibility:
FEMALE
18-45 years
Brief Summary
The National Pregnancy Registry for Psychiatric Medications is dedicated to evaluating the safety of psychiatric medications such as antidepressants, ADHD medications, sedative hypnotics, and atypical...
Detailed Description
The overarching objectives of the National Pregnancy Registry for Psychiatric Medications are twofold: to assess risk for malformations among infants exposed to specific psychiatric medications and to...
Eligibility Criteria
Inclusion
- Pregnant women
- Age 18-45
- Subjects will be willing to participate over the phone
- Subjects will be able to provide informed consent
Exclusion
- Women who have completed their pregnancy
- Women who are planning to become pregnant
- Women who are not taking any psychiatric medications and/or have no history of psychiatric illness
Key Trial Info
Start Date :
November 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2033
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT01246765
Start Date
November 1 2008
End Date
December 1 2033
Last Update
October 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114